Versant Venture Capital VI, L.P.

13D and 13G Filings

13D/G filings: 13D on 4 securities
Location: San Francisco, CA
CIK: 0001687880
Form D filings: 2 filings
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Tempest Therapeutics, Inc. 13D/A Amendment 7 TPST · 87978U108	TPST	87978U108	1.1%	162,972	13D/A Amendment 7	4/2/2026 Event 3/30/2026
Versant Venture Capital VI, L.P.			0.1%	16,149
Versant Ventures VI GP, L.P.			0.1%	16,149
Versant Ventures VI GP-GP, LLC			0.1%	16,149
Versant Vantage II, L.P.			1.1%	162,972
Versant Vantage II GP, L.P.			1.1%	162,972
Versant Vantage II GP-GP, LLC			1.1%	162,972
Versant Venture Capital IV, L.P.			0.6%	90,084
Versant Side Fund IV, L.P.			0%	567
Versant Ventures IV, LLC			0.6%	90,651
Monte Rosa Therapeutics, Inc. 13D/A Amendment 6 GLUE · 61225M102	GLUE	61225M102	3.4%	2,236,708	13D/A Amendment 6	1/9/2026 Event 1/7/2026
Versant Venture Capital VI, L.P.			3.4%	2,236,708
Versant Ventures VI GP, L.P.			3.4%	2,236,708
Versant Ventures VI GP-GP, LLC			3.4%	2,236,708
Versant Vantage I, L.P.			1.6%	1,013,361
Versant Vantage I GP, L.P.			1.6%	1,013,361
Versant Vantage I GP-GP, LLC			1.6%	1,013,361
Monte Rosa Therapeutics, Inc. 13D/A Amendment 5 GLUE · 61225M102	GLUE	61225M102	5.1%	3,334,669	13D/A Amendment 5	11/12/2025 Event 11/10/2025
Versant Venture Capital VI, L.P.			5.1%	3,334,669
Versant Ventures VI GP, L.P.			5.1%	3,334,669
Versant Ventures VI GP-GP, LLC			5.1%	3,334,669
Versant Vantage I, L.P.			2.4%	1,573,453
Versant Vantage I GP, L.P.			2.4%	1,573,453
Versant Vantage I GP-GP, LLC			2.4%	1,573,453
LENZ Therapeutics, Inc. 13D/A Amendment 9 LENZ · 52635N103	LENZ	52635N103	3.4%	1,050,599	13D/A Amendment 9	11/10/2025 Event 11/5/2025
Versant Venture Capital VI, L.P.			3.4%	1,050,599
Versant Ventures VI GP, L.P.			3.4%	1,050,599
Versant Ventures VI GP-GP, LLC			3.4%	1,050,599
Versant Vantage II, L.P.			2.7%	842,162
Versant Vantage II GP, L.P.			2.7%	842,162
Versant Vantage II GP-GP, LLC			2.7%	842,162
Versant Venture Capital VII, L.P.			2.7%	834,661
Versant Ventures VII GP, L.P.			2.7%	834,661
Versant Ventures VII GP-GP, LLC			2.7%	834,661
LAVA Therapeutics N.V. 13D/A Amendment 2 LVTX · N51517105	LVTX	N51517105	0%	0	13D/A Amendment 2	9/23/2025 Event 9/19/2025
Versant Venture Capital VI, L.P.			0%	0
Versant Ventures VI GP, L.P.			0%	0
Versant Ventures VI GP-GP, LLC			0%	0
Versant Vantage I, L.P.			0%	0
Versant Vantage I GP, L.P.			0%	0
Versant Vantage I GP-GP, LLC			0%	0
LENZ Therapeutics, Inc. 13D/A Amendment 8 LENZ · 52635N103	LENZ	52635N103	4.1%	1,183,543	13D/A Amendment 8	9/22/2025 Event 9/18/2025
Versant Venture Capital VI, L.P.			4.1%	1,183,543
Versant Ventures VI GP, L.P.			4.1%	1,183,543
Versant Ventures VI GP-GP, LLC			4.1%	1,183,543
Versant Vantage II, L.P.			3.0%	842,162
Versant Vantage II GP, L.P.			3.0%	842,162
Versant Vantage II GP-GP, LLC			3.0%	842,162
Versant Venture Capital VII, L.P.			3.2%	926,691
Versant Ventures VII GP, L.P.			3.2%	926,691
Versant Ventures VII GP-GP, LLC			3.2%	926,691
LAVA Therapeutics N.V. 13D/A Amendment 1 LVTX · N51517105	LVTX	N51517105	9.0%	2,370,533	13D/A Amendment 1	9/18/2025 Event 9/16/2025
Versant Venture Capital VI, L.P.			9.0%	2,370,533
Versant Ventures VI GP, L.P.			9.0%	2,370,533
Versant Ventures VI GP-GP, LLC			9.0%	2,370,533
Versant Vantage I, L.P.			2.0%	532,870
Versant Vantage I GP, L.P.			2.0%	532,870
Versant Vantage I GP-GP, LLC			2.0%	532,870
LENZ Therapeutics, Inc. 13D/A Amendment 7 LENZ · 52635N103	LENZ	52635N103	4.9%	1,400,220	13D/A Amendment 7	8/20/2025 Event 8/18/2025
Versant Venture Capital VI, L.P.			4.9%	1,400,220
Versant Ventures VI GP, L.P.			4.9%	1,400,220
Versant Ventures VI GP-GP, LLC			4.9%	1,400,220
Versant Vantage II, L.P.			3.0%	842,162
Versant Vantage II GP, L.P.			3.0%	842,162
Versant Vantage II GP-GP, LLC			3.0%	842,162
Versant Venture Capital VII, L.P.			3.6%	1,033,412
Versant Ventures VII GP, L.P.			3.6%	1,033,412
Versant Ventures VII GP-GP, LLC			3.6%	1,033,412
Tempest Therapeutics, Inc. 13D/A Amendment 6 TPST · 87978U108	TPST	87978U108	3.7%	162,972	13D/A Amendment 6	8/13/2025 Event 8/11/2025
Versant Venture Capital VI, L.P.			0.4%	16,149
Versant Ventures VI GP, L.P.			0.4%	16,149
Versant Ventures VI GP-GP, LLC			0.4%	16,149
Versant Vantage II, L.P.			3.7%	162,972
Versant Vantage II GP, L.P.			3.7%	162,972
Versant Vantage II GP-GP, LLC			3.7%	162,972
Versant Venture Capital IV, L.P.			2.0%	90,084
Versant Side Fund IV, L.P.			0%	567
Versant Ventures IV, LLC			2.0%	90,651
LENZ Therapeutics, Inc. 13D/A Amendment 6 LENZ · 52635N103	LENZ	52635N103	5.6%	1,575,899	13D/A Amendment 6	7/14/2025 Event 7/10/2025
Versant Venture Capital VI, L.P.			5.6%	1,575,899
Versant Ventures VI GP, L.P.			5.6%	1,575,899
Versant Ventures VI GP-GP, LLC			5.6%	1,575,899
Versant Vantage II, L.P.			3.0%	842,162
Versant Vantage II GP, L.P.			3.0%	842,162
Versant Vantage II GP-GP, LLC			3.0%	842,162
Versant Venture Capital VII, L.P.			4.0%	1,118,446
Versant Ventures VII GP, L.P.			4.0%	1,118,446
Versant Ventures VII GP-GP, LLC			4.0%	1,118,446
LENZ Therapeutics, Inc. 13D/A Amendment 5 LENZ · 52635N103	LENZ	52635N103	7.0%	1,967,275	13D/A Amendment 5	6/24/2025 Event 6/20/2025
Versant Venture Capital VI, L.P.			7.0%	1,967,275
Versant Ventures VI GP, L.P.			7.0%	1,967,275
Versant Ventures VI GP-GP, LLC			7.0%	1,967,275
Versant Vantage II, L.P.			3.0%	842,162
Versant Vantage II GP, L.P.			3.0%	842,162
Versant Vantage II GP-GP, LLC			3.0%	842,162
Versant Venture Capital VII, L.P.			4.0%	1,118,446
Versant Ventures VII GP, L.P.			4.0%	1,118,446
Versant Ventures VII GP-GP, LLC			4.0%	1,118,446
LENZ Therapeutics, Inc. 13D/A Amendment 4 LENZ · 52635N103	LENZ	52635N103	7.5%	2,101,199	13D/A Amendment 4	6/12/2025 Event 6/10/2025
Versant Venture Capital VI, L.P.			7.5%	2,101,199
Versant Ventures VI GP, L.P.			7.5%	2,101,199
Versant Ventures VI GP-GP, LLC			7.5%	2,101,199
Versant Vantage II, L.P.			3.0%	842,162
Versant Vantage II GP, L.P.			3.0%	842,162
Versant Vantage II GP-GP, LLC			3.0%	842,162
Versant Venture Capital VII, L.P.			4.7%	1,319,323
Versant Ventures VII GP, L.P.			4.7%	1,319,323
Versant Ventures VII GP-GP, LLC			4.7%	1,319,323
Tempest Therapeutics, Inc. 13D/A Amendment 5 TPST · 87978U108	TPST	87978U108	4.8%	2,118,644	13D/A Amendment 5	2/11/2025 Event 11/12/2024
Versant Venture Capital VI, L.P.			0.5%	209,914
Versant Ventures VI GP, L.P.			0.5%	209,914
Versant Ventures VI GP-GP, LLC			0.5%	209,914
Versant Vantage II, L.P.			4.8%	2,118,644
Versant Vantage II GP, L.P.			4.8%	2,118,644
Versant Vantage II GP-GP, LLC			4.8%	2,118,644
Versant Venture Capital IV, L.P.			2.7%	1,171,094
Versant Side Fund IV, L.P.			0%	7,377
Versant Ventures IV, LLC			2.7%	1,178,471

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.